BidaskClub cut shares of Biohaven Pharmaceutical Holding Co Ltd (NASDAQ:BHVN) from a buy rating to a hold rating in a research report sent to investors on Thursday morning.

A number of other research firms also recently commented on BHVN. Zacks Investment Research raised Biohaven Pharmaceutical Holding Co from a sell rating to a hold rating in a report on Monday, August 28th. Morgan Stanley reaffirmed an overweight rating and set a $38.00 target price (down previously from $47.00) on shares of Biohaven Pharmaceutical Holding Co in a report on Tuesday. Needham & Company LLC reaffirmed a buy rating and set a $43.00 target price (up previously from $30.00) on shares of Biohaven Pharmaceutical Holding Co in a report on Wednesday, September 13th. William Blair reaffirmed an outperform rating on shares of Biohaven Pharmaceutical Holding Co in a report on Tuesday. Finally, Piper Jaffray Companies reaffirmed a buy rating and set a $54.00 target price on shares of Biohaven Pharmaceutical Holding Co in a report on Tuesday, September 12th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of Buy and an average price target of $40.80.

Shares of Biohaven Pharmaceutical Holding Co (BHVN) traded up 0.12% during midday trading on Thursday, hitting $32.10. The stock had a trading volume of 99,602 shares. The stock has a 50 day moving average of $35.80 and a 200-day moving average of $27.75. Biohaven Pharmaceutical Holding Co has a one year low of $17.00 and a one year high of $39.51. The company’s market cap is $1.15 billion.

TRADEMARK VIOLATION WARNING: “Biohaven Pharmaceutical Holding Co Ltd (BHVN) Downgraded by BidaskClub to Hold” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/06/biohaven-pharmaceutical-holding-co-ltd-bhvn-downgraded-by-bidaskclub-to-hold.html.

About Biohaven Pharmaceutical Holding Co

Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates.

Analyst Recommendations for Biohaven Pharmaceutical Holding Co (NASDAQ:BHVN)

Receive News & Stock Ratings for Biohaven Pharmaceutical Holding Co Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biohaven Pharmaceutical Holding Co Ltd and related stocks with our FREE daily email newsletter.